Endoscopic Probe Disinfection Market Size & Growth Forecast 2027–2036, By Segments (Type, End Use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Jump to Content
Market Size and Growth Outlook
Endoscopic Probe Disinfection Market size was assessed at USD 527.17 million in 2026 and is poised to grow at a 6.15% CAGR between 2027 and 2036, surpassing USD 957.53 million by 2036. The industry revenue for 2027 is estimated at USD 554.69 million.
Get more details on this report
Request Free Sample ReportEndoscopic Probe Disinfection Market Intelligence Snapshot
Regional Market Dynamics
- North America held 40.94% of the market in 2026, supported by widespread endoscopic procedures, advanced healthcare infrastructure, and strong emphasis on infection prevention, standardized reprocessing, and automated disinfection technologies.
- Asia Pacific is growing fastest as hospital infrastructure expands, endoscopic procedures increase, and healthcare providers strengthen infection-control protocols and invest in automated disinfection solutions to improve patient safety and workflow efficiency.
Segment Momentum
- Endoscopic probes represented 57.88% of the market, reflecting the need for reliable reprocessing between procedures to prevent healthcare-associated infections, maintain device functionality, and support patient safety.
- Ambulatory surgical centers held 46.83% of the market and are also the fastest-growing end-use segment. Expanding outpatient procedures increase demand for reliable disinfection, efficient probe turnaround, and standardized infection-control workflows.
Market Expansion Drivers
- Increasing need for infection control in endoscopic procedures.
- Adoption of automated and advanced probe disinfection systems.
- Rising number of endoscopic procedures in emerging markets.
Leading Market Participants
- Leading companies in the endoscopic probe disinfection market include Olympus (Japan), Pentax Medical (Japan), STERIS (USA), Getinge (Sweden), Cantel Medical (USA), Belimed (Switzerland), Karl Storz (Germany), Medivators (USA), Huida Medical (China), Advanced Sterilization Products (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 527.17 million
- 2027 Estimated Market Size: USD 554.69 million
- Projected Market Size: USD 957.53 million by 2036
- Growth Forecast: 6.15% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Type (Endoscopic Probes) | End Use (Ambulatory Surgical Centers (ASCs))
- Emerging Opportunity Segment: Type (Products) | End Use (Ambulatory Surgical Centers (ASCs))
Market Growth Drivers and Industry Trends
Increasing need for infection control in endoscopic procedures
The increasing emphasis on infection prevention and cross-contamination control is driving demand for effective endoscopic probe disinfection solutions across healthcare facilities. Endoscopic procedures involve repeated use of specialized equipment that can come into contact with biological fluids, creating stringent requirements for reliable cleaning and disinfection between procedures. Growing awareness of healthcare-associated infections, stricter infection control protocols, and greater focus on patient safety are encouraging healthcare providers to strengthen reprocessing practices and adopt standardized disinfection procedures.
Adoption of automated and advanced probe disinfection systems
The adoption of automated and advanced probe disinfection systems is accelerating as healthcare facilities seek to improve the consistency, efficiency, and traceability of endoscope and probe reprocessing. Automated systems can reduce dependence on manual handling, standardize critical disinfection steps, and support reproducible processing outcomes while minimizing the risk of human error. Increasing demand for workflow efficiency, enhanced documentation, and compliance with evolving infection prevention requirements is further encouraging healthcare providers to transition toward sophisticated disinfection technologies.
Rising number of endoscopic procedures in emerging markets
The growing volume of endoscopic procedures in emerging markets is creating greater demand for reliable probe disinfection solutions as healthcare infrastructure and diagnostic capabilities expand. Increasing awareness of minimally invasive diagnostic and therapeutic procedures, improvements in access to specialized medical services, and the expansion of hospitals and ambulatory facilities are contributing to greater utilization of endoscopic equipment. As procedure volumes increase, healthcare providers are placing greater emphasis on efficient reprocessing capacity and standardized infection control practices, supporting market growth.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing need for infection control in endoscopic procedures | 2.5% | Short term (≤ 2 yrs) | North America; Europe | High | Fast |
| Adoption of automated and advanced probe disinfection systems | 2% | Medium term (2–5 yrs) | North America; Europe; Asia Pacific | Medium | Moderate |
| Rising number of endoscopic procedures in emerging markets | 1.5% | Long term (5+ yrs) | Asia Pacific; Latin America | Low | Slow |
Explore Growth Opportunities
Request Free Sample ReportRegional Demand Dynamics
North America (Largest Region)
The North America endoscopic probe disinfection market accounted for a 40.94% share in 2026, supported by advanced healthcare infrastructure, high adoption of endoscopic procedures, and increasing emphasis on infection prevention across healthcare facilities. Growing awareness of healthcare-associated infections is encouraging hospitals and outpatient centers to strengthen reprocessing protocols and adopt reliable disinfection technologies for reusable endoscopic probes. The increasing use of minimally invasive diagnostic and therapeutic procedures is further expanding the need for effective cleaning and disinfection solutions that can support patient safety while maintaining instrument functionality. Healthcare providers are also placing greater emphasis on standardized reprocessing workflows, traceability, and compliance with infection-control practices, creating favorable conditions for specialized probe disinfection systems. In addition, technological improvements in automated disinfection, compatibility with sensitive medical equipment, and workflow efficiency are supporting adoption as healthcare organizations seek to reduce manual processing requirements and improve consistency.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region in the endoscopic probe disinfection market, driven by expanding healthcare infrastructure, increasing adoption of endoscopic procedures, and growing awareness of infection-control practices. Healthcare facilities across emerging markets are investing in modern diagnostic and surgical capabilities, increasing the volume of reusable endoscopic equipment that requires effective reprocessing. Rising healthcare expenditure and the expansion of hospitals and specialized medical centers are further creating demand for reliable disinfection technologies. Growing recognition of the risks associated with inadequate instrument reprocessing is encouraging healthcare providers to strengthen infection-prevention protocols and adopt more standardized cleaning and disinfection procedures. The increasing availability of automated and technologically advanced disinfection solutions is also helping healthcare facilities improve operational efficiency while maintaining consistent processing standards. As minimally invasive procedures become more widely accessible across the region, demand for endoscopic probe disinfection technologies is expected to strengthen.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation HubiScaleNascentDeveloping Advanced | |||||
| Cost-Sensitive RegioniScaleLowMedium High | |||||
| Regulatory EnvironmentiScaleRestrictiveNeutral Supportive | |||||
| Demand DriversiScaleWeakModerate Strong | |||||
| Development StageiScaleEmergingDeveloping Developed | |||||
| Adoption RateiScaleLowMedium High | |||||
| New Entrants / StartupsiScaleSparseModerate Dense | |||||
| Macro IndicatorsiScaleWeakStable Strong |
Key Country Insights
United States 🇺🇸
Automated Reprocessing AdoptionThe U.S. market emphasizes reliable, standardized reprocessing of reusable endoscopic probes, with healthcare providers prioritizing infection-control performance and workflow efficiency. Demand is supported by automation, validated disinfection processes, traceability, and solutions that reduce variability across high-throughput clinical environments.
Germany 🇩🇪
Standardized Reprocessing SystemsGermany's endoscopic probe disinfection market prioritizes rigorous hygiene practices and standardized reprocessing workflows across healthcare facilities. Suppliers should emphasize validated processes, equipment reliability, documentation, and compatibility with institutional infection-prevention protocols when addressing hospitals and specialized diagnostic centers.
Japan 🇯🇵
Precision Hygiene WorkflowsJapan's market places strong value on consistent, precise disinfection procedures for reusable endoscopic equipment. Commercial priorities include compact and reliable reprocessing systems, ease of integration into clinical workflows, and demonstrable adherence to stringent hygiene practices without adding operational complexity.
South Korea 🇰🇷
Technology-Enabled ReprocessingSouth Korea's market is receptive to technology-supported approaches that improve consistency and efficiency in endoscopic probe disinfection. Providers are likely to prioritize automated or semi-automated systems, process monitoring, and equipment compatibility that can strengthen infection-control practices within modern diagnostic and procedural facilities.
France 🇫🇷
Infection-Control ComplianceFrance's endoscopic probe disinfection market is driven by the need for dependable infection-control procedures and consistent equipment reprocessing. Market participants should focus on validated disinfection performance, operator usability, traceability, and alignment with institutional hygiene protocols to support adoption across hospitals and specialist facilities.
Italy 🇮🇹
Workflow Efficiency FocusItaly's market priorities center on maintaining effective probe reprocessing while managing staffing and operational demands within healthcare facilities. Solutions offering repeatable disinfection, straightforward operation, equipment compatibility, and clear process documentation can strengthen adoption among hospitals and outpatient diagnostic settings.
Endoscopic Probe Disinfection Market Share (%), by Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportType Segment Analysis: Endoscopic Probes (Largest Segment) vs Products (Fastest-Growing Segment)
The endoscopic probes segment accounted for the largest share of the endoscopic probe disinfection market, representing 57.88% of the total market share. Endoscopic probes require thorough and reliable disinfection between procedures because they come into contact with patients and may be exposed to biological contaminants during clinical use. Effective reprocessing is essential to reduce the risk of healthcare-associated infections, maintain patient safety, and support compliance with infection prevention protocols. The complexity and sensitivity of endoscopic equipment make appropriate disinfection procedures particularly important, as inadequate processing can compromise both clinical safety and device functionality. Growing utilization of endoscopic procedures across diagnostic and therapeutic settings continues to reinforce the need for specialized disinfection solutions. Meanwhile, the products segment is gaining momentum as healthcare facilities seek more effective and standardized solutions for endoscopic probe reprocessing. Demand encompasses compatible disinfectants, automated reprocessing systems, cleaning accessories, and related consumables that support consistent decontamination workflows. Increasing emphasis on infection control, streamlined equipment turnaround, and reduced manual handling is encouraging adoption of integrated disinfection products that improve operational efficiency while maintaining reliable reprocessing standards.
End Use Segment Analysis: Ambulatory Surgical Centers (ASCs) (Largest & Fastest-Growing Segment)
The ambulatory surgical centers end-use segment accounted for the largest share of the endoscopic probe disinfection market, representing 46.83% of the total market share, while also emerging as the fastest-growing application setting. ASCs increasingly rely on endoscopic technologies for outpatient diagnostic and surgical procedures, creating a need for dependable disinfection processes that support patient safety and efficient clinical operations. Because these facilities often manage tightly scheduled procedure lists, timely and consistent probe reprocessing is essential to maintain equipment availability without compromising infection prevention standards. Appropriate disinfection protocols, compatible chemical agents, and automated reprocessing solutions help facilities establish standardized workflows and reduce the potential for errors associated with manual handling. The growing preference for outpatient care and minimally invasive procedures is strengthening the role of ASCs in endoscopic services. In addition, increasing attention to infection control, operational efficiency, and regulatory compliance is encouraging investment in improved reprocessing infrastructure. The need to balance rapid equipment turnaround with effective decontamination is further supporting demand for specialized endoscopic probe disinfection solutions across ambulatory surgical settings.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Endoscopic Probes, Products | Endoscopic Probes | Products |
| End Use | Hospitals, Ambulatory Surgical Centers (ASCs), Diagnostic Laboratories and Imaging Centers, Others | Ambulatory Surgical Centers (ASCs) | Ambulatory Surgical Centers (ASCs) |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Competitive Landscape and Market Positioning
Analyst Perspective:
Procurement decisions in the endoscopic probe disinfection market are governed by multi-device operational fit and overall workflow velocity rather than isolated performance metrics. Facilities prioritize automated endoscope reprocessor (AER) compatibility to maintain standardized protocols across diverse probe fleets without introducing manual steps or risk of process inconsistency. While rapid turnaround cycles enhance throughput in high-volume settings, commercial viability depends on preserving instrument integrity through proven material durability against repeated chemical exposures. Furthermore, vendors leverage audit-ready traceability and compliance software to integrate cycle data into hospital networks, reducing administrative overhead and ensuring reliable infection-control governance across busy clinical environments.
Key companies in the endoscopic probe disinfection market:
- Olympus (Japan)
- Pentax Medical (Japan)
- STERIS (USA)
- Getinge (Sweden)
- Cantel Medical (USA)
- Belimed (Switzerland)
- Karl Storz (Germany)
- Medivators (USA)
- Huida Medical (China)
- Advanced Sterilization Products (USA)
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Olympus (Japan) | |||||||
| Pentax Medical (Japan) | |||||||
| STERIS (USA) | |||||||
| Getinge (Sweden) | |||||||
| Cantel Medical (USA) | |||||||
| Belimed (Switzerland) | |||||||
| Karl Storz (Germany) | |||||||
| Medivators (USA) | |||||||
| Huida Medical (China) | |||||||
| Advanced Sterilization Products (USA) |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Nanosonics | March 2025 | The FDA cleared the CORIS system, developed to clean complex inner channels of flexible endoscopes and target biofilm buildup. This automated device addresses persistent residues inside narrow endoscope channels that manual brushing often misses, mitigating the risk of hospital-acquired infections caused by resistance to high-level disinfection over multiple cleaning cycles. |
| Amity Ltd. | January 2025 | Introduced SCOPE-Flush, a hands-free, automated flushing system designed to replace manual syringe flushing across all flexible endoscopes. The system delivers a controlled combination of detergent, water, and air to ensure consistent cleaning, minimize manual handling errors, and improve compliance with institutional infection control and disinfection standards. |
| Nanosonics, Inc. | November 2024 | Launched the Trophon Wireless Ultrasound Probe Holder across the U.S. and Canadian markets as a new reusable accessory. Engineered to support rising adoption rates of wireless ultrasound devices, the product helps healthcare facilities streamline infection control protocols and maintain regulatory-compliant high-level disinfection standards. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Endoscopic Probe Disinfection Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Disinfection Method | Chemical Disinfection, Automated Reprocessing, Manual Reprocessing, Other Disinfection Methods |
| Disinfection Level | High-Level Disinfection, Intermediate-Level Disinfection, Low-Level Disinfection |
| Automation Level | Manual Systems, Semi-Automated Systems, Fully Automated Systems |
Endoscopic Probe Disinfection Market — Custom TOC
| Custom Chapter | Chapter Details |
|---|---|
| Reprocessing Workflow Optimization |
|
| Hospital Procurement & Vendor Selection |
|
| Outsourced Reprocessing Models |
|
Need a different cut of the data?
Request Custom ResearchFrequently Asked Questions
How much is the endoscopic probe disinfection market worth?
How is the endoscopic probe disinfection industry size expected to evolve during the forecast period?
How are infection-control priorities influencing endoscopic probe reprocessing investments?
Why are automated disinfection systems gaining importance in endoscopic workflows?
Why do endoscopic probes account for the largest share of the endoscopic probe disinfection market?
Why are ambulatory surgical centers driving growth in endoscopic probe disinfection?
Why does North America lead the endoscopic probe disinfection market?
What is accelerating endoscopic probe disinfection adoption in Asia Pacific?
What are the key competitors in the endoscopic probe disinfection landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
This report was prepared by the Healthcare & Medical Devices Research Team at Fundamental Business Insights, a dedicated research group specializing in the global healthcare and medical technology industry. Our analysts continuously monitor advancements in medical technologies, clinical adoption trends, regulatory developments, reimbursement policies, healthcare infrastructure investments, competitive strategies, and evolving patient care requirements to deliver timely and reliable market intelligence. The research is developed using a structured methodology that combines primary discussions with healthcare stakeholders, company financial disclosures, regulatory publications, clinical literature, government healthcare databases, medical associations, and other authoritative secondary sources. Market estimates are validated through multiple research techniques, including top-down and bottom-up analysis, before undergoing an internal quality review to ensure accuracy, consistency, and methodological integrity prior to publication.
Delivery
Published
Available
Support
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook